6-89387383-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PS1_ModeratePM2PM5PP3_StrongPP5_Moderate
The NM_021244.5(RRAGD):c.356C>G(p.Pro119Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P119L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_021244.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RRAGD | ENST00000369415.9 | c.356C>G | p.Pro119Arg | missense_variant | 2/7 | 1 | NM_021244.5 | ENSP00000358423.4 | ||
RRAGD | ENST00000359203.3 | c.-9-7016C>G | intron_variant | 2 | ENSP00000352131.2 | |||||
RRAGD | ENST00000492783.1 | n.380C>G | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
HYPOMAGNESEMIA 7, RENAL, WITH DILATED CARDIOMYOPATHY Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 08, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.